These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20529040)

  • 1. Carbimazole-induced agranulocytosis: does antineutrophil cytoplasmic antibody have a role?
    Yip G; Ekinci E; Lee ST; Jerums G; Grossmann M
    Intern Med J; 2010 Apr; 40(4):300-3. PubMed ID: 20529040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbimazole induced ANCA positive vasculitis.
    Pandey S; Kushwaha RS; Mehndiratta P; Mehndiratta MM
    J Assoc Physicians India; 2008 Oct; 56():801-3. PubMed ID: 19263707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbimazole-induced agranulocytosis--a report of 2 recent cases.
    Tavintharan S; Rajasoorya C; Chew LS
    Singapore Med J; 1997 Sep; 38(9):386-7. PubMed ID: 9407764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole.
    Vilchez FJ; Torres I; Garcia-Valero A; López-Tinoco C; de Los Santos A; Aguilar-Diosdado M
    Ann Pharmacother; 2006 Nov; 40(11):2059-63. PubMed ID: 17077174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute cholestatic hepatitis along with agranulocytosis: a rare side effect of carbimazole.
    Jain K; Chakrapani M; Smitha K
    Ann Afr Med; 2010; 9(2):102-4. PubMed ID: 20587933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa ecthyma gangrenosum and facial cellulitis complicating carbimazole-induced agranulocytosis.
    del Giudice P; Cua E; Bernard E; Chichmanian RM; Oregionni O; Brucker F; Dellamonica P
    Arch Dermatol; 2006 Dec; 142(12):1663-4. PubMed ID: 17179011
    [No Abstract]   [Full Text] [Related]  

  • 8. [A serious adverse effect: sepsis due to carbimazole].
    Guardiola PD; Tenreiro AP
    Endocrinol Nutr; 2009; 56(7):378-80. PubMed ID: 19883898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graves' disease in a 3 year-old patient with agranulocytosis due to anti-thyroid drugs: Radioiodine ablation therapy as an effective alternative.
    Espinosa-Muñoz E; Ramírez-Ocaña D; Martín-García AM; Ruiz-García FJ; Puentes-Zarzuela C
    Rev Esp Med Nucl Imagen Mol; 2017; 36(4):260-262. PubMed ID: 28392335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent agranulocytosis following carbimazole and propylthiouracil therapy.
    Ostlere S; Apthorp GH
    Br J Clin Pract; 1988 Nov; 42(11):474-5. PubMed ID: 3256337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatality complicating agranulocytosis in the setting of carbimazole therapy.
    Lynch MJ; Woodford NW
    Forensic Sci Med Pathol; 2008; 4(4):246-9. PubMed ID: 19291446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis and agranulocytosis in a patient with Graves' disease.
    Tomkins M; Tudor RM; Smith D; Agha A
    Endocrinol Diabetes Metab Case Rep; 2020 Jan; 2020():. PubMed ID: 31917676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment of agranulocytosis caused by carbimazole using recombinant granulocyte-macrophage colony stimulating factor].
    Kreze A; Kuviková A; Laca L; Kompis S; Dobáková M; Babusík P; Matecek L; Pekárová E
    Vnitr Lek; 1995 Jul; 41(7):470-2. PubMed ID: 7571483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of carbimazole-induced agranulocytosis and sepsis with granulocyte colony stimulating factor.
    Joseph F; Younis N; Bowen-Jones D
    Int J Clin Pract; 2003 Mar; 57(2):145-6. PubMed ID: 12661801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
    McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A
    N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbimazole induced eosinophilic granulomatous vasculitis localized to the stomach.
    Sève P; Stankovic K; Michalet V; Vial T; Scoazec JY; Broussolle C
    J Intern Med; 2005 Aug; 258(2):191-5. PubMed ID: 16018796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of carbimazole-induced agranulocytosis following recombinant granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration.
    Meletis J; Vavourakis S; Andreopoulos T; Yataganas X; Poziopoulos C; Lafioniatis S; Konstantopoulos K; Loukopoulos D
    Haematologica; 1993; 78(5):329-31. PubMed ID: 8314163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent episodes of arthritis in a hyperthyroid patient.
    Tan F; Nam TQ; Lee KO; Cheah WK; Mukherjee JJ
    Singapore Med J; 2006 Feb; 47(2):163-5. PubMed ID: 16435062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced sensorineural deafness caused by antithyroid drugs: a rare side effect.
    Raja UY; Kumar A; Possamai V; Warner D; Barton D
    J R Coll Physicians Edinb; 2010 Sep; 40(3):219-20. PubMed ID: 21127764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of outcome in Graves' disease after carbimazole treatment.
    Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
    Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.